SCHEMBL8392602

SCHEMBL8392602

CNC(=O)N(C(=O)Cc1ccc(OC)c(N=S(=O)=O)c1)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CNR2 P34972 5/20 0.38
▸ PKM P14618 1/20 0.38
▸ FAAH O00519 1/20 0.37
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ GPR55 Q9Y2T6 1/20 0.36
▸ LMNA P02545 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ TOP2A P11388 3/20 0.35
▸ HDAC11 Q96DB2 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ P2RX5 Q93086 1/20 0.34
▸ P2RX4 Q99571 1/20 0.34
▸ P2RX7 Q99572 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8341312 0.92 POLB (0.38) POLBSMN1; SMN2CNR2PKMFAAH
SCHEMBL8334265 0.83 CNR2 (0.35) POLBSMN1; SMN2CNR2KMT2AMEN1
SCHEMBL8393920 0.81 POLB (0.36) POLBSMN1; SMN2CNR2PKMKMT2A
SCHEMBL8865201 0.80 CNR2 (0.37) POLBSMN1; SMN2CNR2PKMFAAH
SCHEMBL8336152 0.80 CNR2 (0.37) POLBSMN1; SMN2CNR2PKMFAAH
SCHEMBL8335569 0.79 GAA (0.40) SMN1; SMN2KMT2AMEN1LMNAALDH1A1
SCHEMBL8341129 0.79 CNR2 (0.35) SMN1; SMN2CNR2LMNAALDH1A1P2RX7
SCHEMBL8340166 0.77 GAA (0.39) SMN1; SMN2KMT2AMEN1LMNAALDH1A1
SCHEMBL8333062 0.77 GAA (0.36) POLBSMN1; SMN2CNR2PKMKMT2A
SCHEMBL8339480 0.77 IARS1 (0.38) POLBSMN1; SMN2KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback